1 |
Van den Bergh L, Joniau S, Haustermans K, et al. Reliability of sentinel node procedure for lymph node staging in prostate cancer patients at high risk for lymph node involvement [J]. Acta Oncol, 2015, 54(6): 896-902.
|
2 |
Lenghel LM, Bolboacă SD, Botar-Jid C, et al. The value of a new score for sonoelastographic differentiation between benign and malignant cervical lymph nodes [J]. Med Ultrason, 2012, 14(4): 271-277.
|
3 |
李鑫,杜联芳.超声造影在淋巴结转移癌诊断中的应用及前景[J/CD].中华医学超声杂志(电子版),2017,14(3):174-176.
|
4 |
Galiè M, D'Onofrio M, Montani M, et al. Tumor vessel compression hinders perfusion of ultrasonographic contrast agents [J]. Neoplasia, 2005, 7(5): 528-536.
|
5 |
Steinkamp HJ, Wissgott C, Rademaker J, et al. Current status of power Doppler and color Doppler sonography in the differential diagnosis of lymph node lesions [J]. Eur Radiol, 2002, 12(7): 1785-1793.
|
6 |
Schulte-Altedorneburg G, Demharter J, Linné R, et al. Does ultrasound contrast agent improve the diagnostic value of colour and power Doppler sonography in superficial lymph node enlargement? [J]. Eur J Radiol, 2003, 48(3): 252-257.
|
7 |
Ryoo I, Suh S, You SH, et al. Usefulness of microvascular ultrasonography in differentiating metastatic lymphadenopathy from tuberculous lymphadenitis [J]. Ultrasound Med Biol, 2016, 42(9): 2189-2195.
|
8 |
Cazaentre T, Morschhauser F, Vermandel M, et al. Pre-therapy18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma [J]. Eur J Nucl Med Mol Imaging, 2010, 37(3): 494-504.
|
9 |
Pei XQ, Liu LZ, Zheng W, et al. Contrast-enhanced ultrasonography of hepatocellular carcinoma:correlation between quantitative parameters and arteries in neoangiogenesis or sinusoidal capillarization [J]. Eur J Radiol, 2012, 81(3): e182-e188.
|
10 |
Steinkamp HJ, Wissgott C, Rademaker J, et al. Current status of power Doppler and color Doppler sonography in the differential diagnosis of lymph node lesions [J]. Eur Radiol, 2002, 12(7): 1785-1793.
|
11 |
Querellou S, Valette F, Bodet-Milin C, et al. FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease [J]. Ann Hematol, 2006, 85(11): 759-767.
|
12 |
Yu M, Liu Q, Song HP, et al. Clinical application of contrast-enhanced ultrasonography in diagnosis of superficial lymphadenopathy [J]. J Ultrasound Med, 2010, 29(5): 735-740.
|
13 |
Nakase K, Yamamoto K, Hiasa A, et al. Contrastenhanced ultrasound examination of lymph nodes in different types of lymphoma [J]. Cancer Detect Prev, 2006, 30(2): 188-191.
|
14 |
Cui XW, Jenssen C, Saftoiu A, et al. New ultrasound techniques for lymph node evaluation [J]. World J Gastroenterol, 2013, 19(30): 4850-4860.
|
15 |
Rubaltelli L, Khadivi Y, Tregnaghi A, et al. Evaluation of lymph node perfusion using continuous mode harmonic ultrasonography with a second-generation contrast agent [J]. J Ultrasound Med, 2004, 23(6): 829-836.
|
16 |
Stramare R, Scagliori E, Mannucci MA, et al. The role of contrast-enhanced gray-scale ultrasonography in the differential diagnosis of superficial lymph nodes [J]. Ultrasound Q, 2010, 26(1): 45-51.
|
17 |
Deaver D, Horna P, Cualing H, et al. Pathogenesis, diagnosis, and management of Kikuchi-Fujimoto disease [J]. Cancer Control, 2014, 21(4): 313-321.
|
18 |
Niu X, Jiang W, Zhang X, et al. Comparison of contrastenhanced ultrasound and positron emission tomography/computed tomography (PET/CT) in lymphoma [J]. Med Sci Monit, 2018, 24(24): 5558-5565.
|
19 |
章建全.应用高频超声造影评价浅表病灶微循环灌注的缺陷及初步解决方案 [J].第二军医大学学报,2007,28(11):1193-1196.
|
20 |
Hong YR, Luo ZY, Mo GQ, et al. Role of Contrast-Enhanced Ultrasound in the Pre-operative Diagnosis of Cervical LymphNode Metastasis in Patients with Papillary Thyroid Carcinoma [J]. Uitrasound Med Biol, 2017, 43(11): 2567-2575.
|